Access cutting-edge plaque psoriasis treatment through this clinical trial at a research site in Arlington. Study-provided care at no cost to qualified participants.
Access plaque psoriasis specialists in Arlington at no cost
This study follows strict safety protocols and ethical guidelines
All study-related plaque psoriasis treatment provided free
The primary purpose of this study is to evaluate the efficacy of bimekizumab administered subcutaneously (sc) compared to active control (ustekinumab) in children and adolescents aged 6 to \<18 years of age with moderate to severe plaque psoriasis (PSO).
Sponsor: UCB Biopharma SRL
Check if you qualify for this plaque psoriasis clinical trial in Arlington, TX
If you're searching for plaque psoriasis treatment options in Arlington, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Arlington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced plaque psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.